Fideicomiso Irrevocable F/2061 FHipo (FHIPO14) Fair Value & Analysis
Financial Services · MX · Market cap 34.9B MXN
Fair value as of: Jul 20, 2026
From 6 valuation models · updated 20 days ago
Share price −0.7% over the past month.
Below-average quality, and screening another 45% overvalued on our models.
What matters now
- The price sits above even our optimistic bull case (9.89 MXN). The favourable scenario is already priced in.
- Solid but not exceptional quality (49/100) and above fair value, neither a clear bargain nor a standout compounder.
- For a financial, book-value and earnings-based methods matter more than a cash-flow DCF, which fits banks and insurers poorly.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 20, 2026.
How to read this chart
60‑month range 8.29 MXN – 15.23 MXN · fair‑value band 5.94 MXN – 9.89 MXN · the 14.30 MXN price screens above the 7.91 MXN fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Jul 20, 2026.
Analysis
Fideicomiso Irrevocable F/2061 FHipo (FHIPO14) currently trades at 14.30 MXN, while our model-based Fair Value estimate is 7.91 MXN, implying the stock looks roughly 44.7% overvalued today. The Quality Score stands at 49/100 (below-average quality), in the Financial Services sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: medium).
Over the trailing twelve months, Fideicomiso Irrevocable F/2061 FHipo generated revenue of 475M MXN at a net margin of 13.8%. Revenue declined 85.9% year over year. It earns a return on equity of 0.7%. Net debt stands at 2.9B MXN. Fundamentals as of Jul 20, 2026
Our scenario range runs from 5.94 MXN (bear case) to 9.89 MXN (bull case); at 14.30 MXN, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 6% below its 52-week high and 23% above its 52-week low, currently above its 200-day average. For context, the median of 10 Financial Services peers we cover trades at 42% fair-value upside, at -45%, FHIPO14 screens richer than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 6 models by family
Widest divergence: Multiples (6.73 MXN) versus Dividend Discount (0.7300 MXN). Highest evidence: Residual Income (76).
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Jul 20, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 38 · Market factors (momentum, volatility) 65
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Fideicomiso Irrevocable F/2061 FHipo engages in acquiring, originating, co-participating, and managing mortgage portfolios in Mexico. The company was incorporated in 2014 and is based in Mexico City, Mexico.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2023 · reported fiscal years
Fideicomiso Irrevocable F/2061 FHipo reported revenue of 7.3B MXN in FY2023 versus 4.4B MXN in FY2021, a compound +28.7%/yr. Reported net income was 965M MXN in FY2023, compounding +15.6%/yr from FY2021.
FHIPO14 screens 45% overvalued. Compare with PT Bank Central Asia Tbk →
Peer Group
Banks - Regional · 1083 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Banks - Regional median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
VALUE 0: the price sits above our fair-value range.
Insider activity: 35/100
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Banks - Regional stocks, each showing price versus our Fair Value estimate (as of Jul 20, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| PT Bank Central Asia Tbk BBCA | 6,175 IDR | 6,087 IDR | -1% |
| KB Financial Group 105560 | 184,400 KRW | 213,797 KRW | +16% |
| PT Bank Rakyat Indonesia (Persero) Tbk BBRI | 2,970 IDR | 4,891 IDR | +65% |
| PT Bank Mandiri (Persero) Tbk BMRI | 4,310 IDR | 7,841 IDR | +82% |
| Banco Bradesco S.A BBD | 5,120 ARS | 10,240 ARS | +100% |
| Shinhan Financial Group 055550 | 107,900 KRW | 137,259 KRW | +27% |
| Hana Financial Group 086790 | 136,800 KRW | 193,969 KRW | +42% |
| Lloyds Banking Group LYG | 4,138 ARS | 8,275 ARS | +100% |
| Banco de Chile, CHILE | 193.10 CLP | 152.55 CLP | -21% |
| Joint Stock Commercial Bank for Foreign Trade of Vietnam, VCB | 59,400 VND | 84,201 VND | +42% |
Compare Fideicomiso Irrevocable F/2061 FHipo with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Financial Services stocks →
Frequently asked questions
Is Fideicomiso Irrevocable F/2061 FHipo (FHIPO14) overvalued or undervalued?
What is the fair value of FHIPO14?
What is the quality score of FHIPO14?
What is the revenue of Fideicomiso Irrevocable F/2061 FHipo (FHIPO14)?
What is the net profit margin of FHIPO14?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Fideicomiso Irrevocable F/2061 FHipo and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.